TALECRIS VISION
CORPORATE SITES
Talecris Canada
Talecris Europe
Talecris United States
View All
PRODUCT SITES
Alpha-1 Antitrypsin Deficiency
(Prolastin/Prolastina)
Immune Globulin Intravenous
Therapy
(IGIV) (Gamunex)
Antihemophilic Factor VIII
(Koāte-DVI)
Antithrombin III (AT III)
(Thrombate)
Human Albumin Products
(Plasbumin / Plasmanate)
Hyperimmune Globulin Therapy
(Hypermunes)
View All
PROGRAMS & SERVICES
Gamunex Connexions
Gamunex Direct
Prolastin Direct
Contract Manufacturing Services
Talecris Plasma Resources
View All
CONTACT TALECRIS
Home
About Talecris
Therapeutic Areas
Research & Development
Donor to Patient
Business Development
Investor Relations
Media Center
Media Center Overview
Press Releases
News Features
The History of Talecris
Talecris Leadership
Talecris Media Contact Information
Media Center Overview
Talecris Media Contact Information
Our media line:
(+1) 919 316 6316
Our mailing address:
Talecris Biotherapeutics, Inc.
Attn: Corporate Communications
PO Box 110526
4101 Research Commons
79 T.W. Alexander Drive
Research Triangle Park
North Carolina, 27709 USA
Contact Talecris
Glossary
Site Map
General Conditions of Use
Privacy Statement
California Compliance
© 2009 Talecris Biotherapeutics
